US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.915
  • +0.035+3.99%
Close Dec 20 16:00 ET
  • 0.915
  • 0.0000.00%
Post 16:00 ET
50.28MMarket Cap-2.54P/E (TTM)

About Cytosorbents Company

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Company Profile

SymbolCTSO
Company NameCytosorbents
Listing DateDec 23, 2014
Founded1997
CEODr. Phillip P. Chan, M.D.,PhD
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
Address305 College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-732-329-8885
Websitehttp://cytosorbents.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Phillip P. Chan, M.D.,PhD
  • Chief Executive Officer and Director
  • 1.33M
  • Dr. Efthymios Nikolaos Deliargyris, M.D.
  • Chief Medical Officer
  • 1.06M
  • Peter J. Mariani
  • Chief Financial Officer
  • --
  • Vincent J. Capponi, M.S.
  • President and Chief Operating Officer
  • 1.11M
  • Michael G. Bator
  • Chairman of the Board
  • 161.70K
  • Dr. Edward R. Jones, M.B.A.,M.D.
  • Independent Director
  • 101.93K
  • Jiny Kim, M.B.A.
  • Independent Director
  • 101.80K
  • Alan D. Sobel, C.P.A.
  • Independent Director
  • 118.47K
Heat List
US
Overall
Symbol
Price
% Chg

No Data